Assessing Cardiovascular Risk through Insulin Resistance and Inflammation

Many chronic conditions, including Cardiovascular Disease, Type II Diabetes, Chronic Kidney Disease, Non-Alcoholic Fatty

Liver Disease are rooted in insulin resistance and are clinically silent in their early stages. Identification of early metabolic

dysfunction provides a unique opportunity for stage-targeted intervention and management to prevent disease progression.

• Review population health trends in cardiovascular mortality and metabolic dysfunction

• Discuss how metabolic dysfunction contributes to cardiovascular disease and other chronic conditions

• Learn about the clinical solution for early identification of metabolic risk

***As a courtesy, Vasolabs will be offering FREE Mini CIMT's to those providers who are in attendance**

Event Venue & Nearby Stays

Prati Italia, 4972 Big Island Drive, Jacksonville, United States